You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
21 December 2009
TAVARGENIX GmbH: Inhibition of sugar metabolism in cancer cells as target for cancer therapy confirmed by researchers from Johns Hopkins University
30 January 2009
TAVARGENIX GmbH: TKTL1 validated as a new concept for combating aggressive tumors